Innovative thinking on how to prevent malaria

#BOHEMIAproject

Malaria elimination will not be possible in many settings with the current available tools. Vector control, our most effective strategy, is now challenged by widespread insecticide resistance and mosquitoes that avoid insecticides in bednets and sprayed indoors by biting outdoors, feeding upon animals or changing their biting times.

The BOHEMIA project, funded by Unitaid, will develop an innovative strategy to complement the existing tools: administer ivermectin (a mosquito-killing drug) to humans and livestock to reduce malaria transmission.

Bohemia
in numbers

Bohemia
in numbers

0
countries
0
drug

for people
& animals

0MDA
campaign
0
partners

Let’s introduce
our work

Ivermectin is an anti-parasitic drug that kills mosquitoes feeding on treated subjects. Mass drug administration of ivermectin to humans and/or livestock tackles residual malaria transmission.

It targets mosquitoes that feed on treated humans regardless of the place and time of biting, as well as mosquitoes that feed partly on livestock and are not routinely exposed to insecticide within the home.

The time has come to
bite them back

Let’s introduce
our work

Ivermectin is an anti-parasitic drug that kills mosquitoes feeding on treated subjects. Mass drug administration of ivermectin to humans and/or livestock tackles residual malaria transmission.

It targets mosquitoes that feed on treated humans regardless of the place and time of biting, as well as mosquitoes that feed partly on livestock and are not routinely exposed to insecticide within the home.

The time has come to bite them back

SubscribeSubscribe to
our newsletter

Receive updates -twice a year-
on the BOHEMIA project

Update me on the project

SubscribeSubscribe to
our newsletter

Receive updates -twice a year-
on the BOHEMIA project

Update me on the project

Whats’s new

All roads lead to Mopeia: the role of animals in a malaria trial

Photo courtesy: Canva Bringing in veterinarians to fight malaria Mussa Sale joined the BOHEMIA project as an archivist, to file informed consent forms gathered during the ...
read more

BOHEMIA Launches Mass Administration of Ivermectin in Mozambique to Fight Malaria

Ivermectin will be distributed to humans and livestock with an aim to reduce malaria transmissionBOHEMIA launches its first round of mass drug administration (MDA) of ivermectin ...
read more

“The world needs more tools in the malaria toolbox”

Mary-Ann Richardson is BOHEMIA’s clinical trial manager. She initially joined the project as a contractor providing support and developing infrastructure for the clinical trial. In November ...
read more